Foundayo Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
17:31
Apr 30
Apr 30
Foundayo launch strong, expanding GLP-1 market.
Foundayo (oral GLP-1 pill) is off to a strong start with >20,000 patients in 20 days, >80% new to category, expanding the market. The pill is easy to take, scalable, and has a long runway given only ~20 million patients treated vs. potential billion. The ramp will be slower due to new brand/molecule but does not change long-term outlook.
HIGH
About Foundayo Investor Commentary
Across the available history and selected sources, Buzzberg tracks Foundayo across 1 sources: 1 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Latest voices: Dave Ricks.